Skip to main content
SpringerLink
Log in

Antivirale Pharmaka

  • Chapter
  • First Online:
Pharmakologie und Toxikologie

  • 31k Accesses

Zusammenfassung

Viren haben keinen eigenen Stoffwechsel. Sie müssen in Wirtszellen eindringen und die zelluläre Maschinerie für die Replikation der eigenen genetischen Information (virale DNA oder RNA), die Synthese der viralen Proteine sowie die Assemblierung und den Export des infektiösen Viruspartikels nutzen. Die selektive pharmakologische Hemmung der viralen Vermehrung ist daher ein Problem. Dennoch sind mittlerweile einige Angriffspunkte erkannt worden, die bei einzelnen Viren eine spezifische Intervention erlauben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Weiterführende Literatur

  • Brown KC, Paul S, Kashuba AD (2009) Drug interactions with new and investigational antiretrovirals. Clin Pharmacokinet 48:211–241

    Article  CAS  Google Scholar 

  • EASL Clinical Practice Guidelines (2009) Management of chronic hepatitis B. J Hepatol 50:227–242

    Article  Google Scholar 

  • European Association for the Study of the Liver (2018) EASL recommendations on treatment of hepatitis C 2018. J Hepatol 69:461–511

    Article  Google Scholar 

  • Fransen S, Gupta S, Danovich R, Hazuda D, Miller M, Witmer M, Petropoulos CJ, Huang W (2009) Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways. J Virol 83:11440–11446

    Article  CAS  Google Scholar 

  • Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation N Engl J Med 360: 692–698

    Google Scholar 

  • Manosuthi W, Sungkanuparph S, Tantanathip P, Lueangniyomkul A, Mankatitham W, Prasithsirskul W, Burapatarawong S, Thongyen S, Likanonsakul S, Thawornwa U, Prommool V, Ruxrungtham K; N2R Study Team (2009) A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R study. Clin Infect Dis 48:1752–1759

    Article  Google Scholar 

  • Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P (2014) Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59:318–327

    Article  Google Scholar 

  • Burlone ME, Budkowska A (2009) Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J Gen Virol 90:1055–1070

    Article  CAS  Google Scholar 

  • Romano KP, Ali A, Aydin C, Soumana D, Ozen A, Deveau LM, Silver C, Cao H, Newton A, Petropoulos CJ, Huang W, Schiffer CA (2012) The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors. PLoS Pathog 8(7):e1002832

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrum für Physiologie und Pharmakologie, Medizinische Universität Wien, Wien, Österreich

    Michael Freissmuth

Authors
  1. Michael Freissmuth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Freissmuth .

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Freissmuth, M. (2020). Antivirale Pharmaka. In: Pharmakologie und Toxikologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-58304-3_58

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-58304-3_58

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-58303-6

  • Online ISBN: 978-3-662-58304-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation